Treatment with the immunotherapy dostarlimab showed promising results in a small trial of a dozen rectal cancer patients, according to new research, but further study is needed and it is too early to call it a cure. CNN’s Erin Burnett speaks to Dr. Andrea Cercek, an oncologist at Memorial Sloan Kettering Cancer Center.
More News
Mother of Hamas hostage reacts to discovering Hamas accepted ceasefire proposal | CNN
Building African infrastructure to ease trade | CNN
How the British Empire left its mark on the world | CNN